Hochreiter M, et al. - Experts evaluated whether or not the prolonged antibiotic prophylaxis beyond a single perioperative dose was advantageous in preventing pulmonary infection after thoracoabdominal esophagectomy. The effect of a 5-day postoperative course of moxifloxacin, which is a frequently used antimicrobial agent for pneumonia, on the incidence of pulmonary infection and mortality after thoracoabdominal esophagectomy was assessed. The incidence of pulmonary infection was not seen to decrease with a preemptive 5-day postoperative course of moxifloxacin and no improvement in the mortality after thoracoabdominal esophagectomy was seen.